| |
| |
|
| Insider
Information: |
Hutson Nancy J |
| Relationship: |
Director |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
212,328 |
|
|
Indirect Shares
|
5,000 |
|
|
| Direct
Value |
$635,647 |
|
|
|
Indirect Value
|
$1 |
|
|
| Total
Shares |
217,328 |
|
|
| Total
Value |
$635,648 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
3
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 9.3%
|
 -30.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endo Health Solutions Inc |
ENDP |
Director |
2014-02-28 |
0 |
2010-12-07 |
1,000 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-14 |
81,818 |
|
0 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
37,510 |
2023-05-19 |
4,000 |
Premium* |
|
|
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-10-03 |
93,000 |
2020-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2016-12-01 |
4 |
A |
$5.59 |
$9,995 |
D/D |
1,788 |
28,664 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2017-03-01 |
4 |
A |
$6.24 |
$9,996 |
D/D |
1,602 |
30,266 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2017-06-01 |
4 |
A |
$5.15 |
$9,996 |
D/D |
1,941 |
32,207 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2017-09-01 |
4 |
A |
$5.10 |
$9,996 |
D/D |
1,960 |
34,167 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2017-12-01 |
4 |
A |
$5.08 |
$9,997 |
D/D |
1,968 |
36,135 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2020-06-01 |
4 |
A |
$4.50 |
$9,997 |
D/D |
2,224 |
62,111 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2019-12-01 |
4 |
A |
$2.85 |
$9,998 |
D/D |
3,508 |
56,554 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2018-06-01 |
4 |
A |
$6.43 |
$9,999 |
D/D |
1,555 |
39,702 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2019-09-01 |
4 |
A |
$2.99 |
$9,999 |
D/D |
3,344 |
43,046 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2020-03-01 |
4 |
A |
$3.00 |
$9,999 |
D/D |
3,333 |
59,887 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2016-09-01 |
4 |
A |
$4.11 |
$10,000 |
D/D |
2,433 |
26,876 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2018-03-01 |
4 |
A |
$4.97 |
$10,000 |
D/D |
2,012 |
38,147 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2019-11-18 |
4 |
B |
$1.45 |
$14,500 |
D/D |
10,000 |
53,046 |
2.39 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2021-03-12 |
4 |
B |
$3.11 |
$15,525 |
D/D |
5,000 |
10,000 |
2.39 |
% |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2021-08-16 |
4 |
B |
$5.68 |
$17,040 |
D/D |
3,000 |
13,000 |
2.39 |
% |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2021-11-08 |
4 |
OE |
$3.15 |
$23,310 |
D/D |
7,400 |
33,760 |
0 |
- |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2010-12-07 |
4 |
B |
$36.38 |
$36,380 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2022-11-17 |
4 |
B |
$1.33 |
$39,900 |
D/D |
30,000 |
83,000 |
2.39 |
% |
|
| ENDP |
Endo Health Solutions Inc |
Director |
– • – |
2009-05-13 |
4 |
B |
$16.31 |
$48,930 |
D/D |
3,000 |
6,908 |
2.39 |
- |
|
| PHAS |
Phasebio Pharmaceuticals ... |
Director |
– • – |
2021-11-05 |
4 |
OE |
$2.26 |
$60,909 |
D/D |
26,360 |
26,360 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-06-10 |
4 |
OE |
$2.85 |
$73,549 |
D/D |
23,333 |
88,406 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • – |
2021-10-29 |
4 |
OE |
$2.00 |
$81,350 |
D/D |
40,000 |
53,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2015-02-20 |
4 |
B |
$10.27 |
$102,700 |
D/D |
10,000 |
15,891 |
2.39 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-06-14 |
4 |
S |
$8.04 |
$103,443 |
D/D |
(12,866) |
81,818 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-10-15 |
4 |
OE |
$1.71 |
$363,450 |
D/D |
105,000 |
170,073 |
0 |
- |
|
52 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
